Awani Review

Complete News World

The clinic is preparing to mobilize for Pink October

The clinic is preparing to mobilize for Pink October

Established since 1985, with more than 7,200 interventions annually, the Teras Sanatorium decided for several years to focus on screening and raising awareness among the population.

“We must take patients into their own hands and offer them a full range of services and professionals who are able to respond to an organized care path.” Regis Buisson, President, tells us.

‘We are far from systematic mastectomy’

When Pink October is mentioned every year, it’s clear that the first thought favors women and their high risk of breast cancer.

Hence the necessity of increasing all events and structures for the benefit of examination.

For this purpose, the clinic has high-performance radiological examination equipment, including a digital stereotactic mammogram that allows a biopsy to be performed on a small area of ​​calcification for accurate diagnosis and localization.

Screening techniques have also evolved significantly as mammography machines have become much less painful.

All stages from screening to surgery, including chemotherapy and immunotherapy, have seen very significant improvements.

We are far from systematic mastectomy. Each treatment is adapted to each case.” Jean-François Debray, visceral surgeon and head of the foundation’s medical committee, tells us.

This day also raised patients’ awareness of primary self-care through self-palpation.

“A severe shortage of doctors’ treatment”

The development of medical deserts does not help in statistics on the number of examination requests.

Every year we receive about fifty patients who have undergone late examinations and for whom a mastectomy is necessary. That’s a lot !” Explains Dr. Debray, who on this day was wearing a pink jacket and pants in the operating room.

See also  The eruption caused waves to go beyond the limits of space

Remember, men are not excluded from screening either. The positivity of the latter, despite its rarity, necessarily generates search for familial genetic risks. This disease is often underdiagnosed due to its low incidence (0.5% of male cancer cases).